Tag: Merck

All

FDA Authorizes Merck’s COVID-19 Antiviral Pill Molnupiravir

The FDA issued emergency authorization for Merck’s molnupiravir for the treatment of mild-to-moderate COVID-19 in adults age 18 and older with positive results of direct SARS-CoV-2 viral testing.

European Commission Approves Merck’s VaxNeuvance Pneumococcal Vaccine
Success of Covid Antiviral Pills Hinges on Access to Speedy and Accurate Tests
Merck to License COVID-19 Antiviral to Drugmakers in Other Companies
Merck’s COVID-19 Antiviral Pill Cut Prevented Mortality, Cut Hospitalization Risks in Half
FDA: New Merck Pneumonia Vaccine OK’d
Merk’s Experimental Lung Cancer Drug Fails Trial
Positive Data for Merck’s Pneumococcal Conjugate Vaccine Candidate

All

Merck’s Sublingual Allergen Ragwitek Approved By FDA For Ragweed Allergies

The FDA has approved Ragwitek, a sublingual allergen extract to treat short ragweed pollen induced allergic rhinitis (hay fever) in adults 18 years through 65 years of age.

FDA Approves Merck’s Sublingual Allergen Grastek

Tag: Merck

All

FDA Authorizes Merck’s COVID-19 Antiviral Pill Molnupiravir

European Commission Approves Merck’s VaxNeuvance Pneumococcal Vaccine

Success of Covid Antiviral Pills Hinges on Access to Speedy and Accurate Tests

Merck to License COVID-19 Antiviral to Drugmakers in Other Companies

Merck’s COVID-19 Antiviral Pill Cut Prevented Mortality, Cut Hospitalization Risks in Half

FDA: New Merck Pneumonia Vaccine OK’d

Merk’s Experimental Lung Cancer Drug Fails Trial

Positive Data for Merck’s Pneumococcal Conjugate Vaccine Candidate

All

Merck’s Sublingual Allergen Ragwitek Approved By FDA For Ragweed Allergies

FDA Approves Merck’s Sublingual Allergen Grastek

All

Sorry, No Posts Found

Sorry, No Posts Found